Ulcerative Colitis Chronic Mild
11
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
80.0%
-6.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Broccoli Sprouts for Mild Ulcerative Colitis
Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
Combination of Diet and Oral Budesonide for Ulcerative Colitis
Preliminary Clinical Study of NMN Intervention in Mild Ulcerative Colitis
Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients
Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
The Safety and Efficacy of TET Enema in the Treatment of UC
Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC
Monocultivar Coratina Extra Virgin Olive Oil in UC Patients